Literature DB >> 2364435

Human red cell glucose-6-phosphate dehydrogenase: all active enzyme has sequence predicted by the X chromosome-encoded cDNA.

E Beutler1, T Gelbart, W Kuhl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2364435     DOI: 10.1016/0092-8674(90)90231-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  5 in total

1.  Transcription-related human disorders.

Authors:  J E Cleaver; M L Hultner
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

2.  PharmGKB summary: very important pharmacogene information for G6PD.

Authors:  Ellen M McDonagh; Caroline F Thorn; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-03       Impact factor: 2.089

3.  Cloning and functional characterization of GMPR2, a novel human guanosine monophosphate reductase, which promotes the monocytic differentiation of HL-60 leukemia cells.

Authors:  Jia Zhang; Weiping Zhang; Dajin Zou; Guoyou Chen; Tao Wan; Minghui Zhang; Xuetao Cao
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-01       Impact factor: 4.553

4.  Degradation of brown adipocyte purine nucleotides regulates uncoupling protein 1 activity.

Authors:  Tobias Fromme; Karin Kleigrewe; Andreas Dunkel; Angelika Retzler; Yongguo Li; Stefanie Maurer; Natascha Fischer; Rolf Diezko; Timo Kanzleiter; Verena Hirschberg; Thomas Hofmann; Martin Klingenspor
Journal:  Mol Metab       Date:  2017-12-26       Impact factor: 7.422

5.  Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration.

Authors:  Guan Wang; Jérôme Durussel; Jonathan Shurlock; Martin Mooses; Noriyuki Fuku; Georgie Bruinvels; Charles Pedlar; Richard Burden; Andrew Murray; Brendan Yee; Anne Keenan; John D McClure; Pierre-Edouard Sottas; Yannis P Pitsiladis
Journal:  BMC Genomics       Date:  2017-11-14       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.